BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV Jr, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol 2015;13:847-58.e4; quiz e48-50. [PMID: 24879926 DOI: 10.1016/j.cgh.2014.05.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Matondo A, Kim SS. Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease. Journal of Drug Targeting 2018;26:1-8. [DOI: 10.1080/1061186x.2017.1339196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Vincent G, Novak EA, Siow VS, Cunningham KE, Griffith BD, Comerford TE, Mentrup HL, Stolz DB, Loughran P, Ranganathan S, Mollen KP. Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation. Antioxid Redox Signal 2020;33:1-19. [PMID: 32103677 DOI: 10.1089/ars.2018.7702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yan B, Pan C, Mao X, Yang L, Liu Y, Yan L, Mu H, Wang C, Sun K, Liao F, Fan J, Wang X, Han J. Icariside II improves cerebral microcirculatory disturbance and alleviates hippocampal injury in gerbils after ischemia–reperfusion. Brain Research 2014;1573:63-73. [DOI: 10.1016/j.brainres.2014.05.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
4 Glover LE, Lee JS, Colgan SP. Oxygen metabolism and barrier regulation in the intestinal mucosa. J Clin Invest. 2016;126:3680-3688. [PMID: 27500494 DOI: 10.1172/jci84429] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
5 Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A, Weir TL, Ehrentraut SF, Pickel C, Kuhn KA, Lanis JM, Nguyen V, Taylor CT, Colgan SP. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015;17:662-671. [PMID: 25865369 DOI: 10.1016/j.chom.2015.03.005] [Cited by in Crossref: 601] [Cited by in F6Publishing: 552] [Article Influence: 85.9] [Reference Citation Analysis]
6 Sun TY, Li YQ, Zhao FQ, Sun HM, Gao Y, Wu B, Yang S, Ji FQ, Zhou DS. MiR-1-3p and miR-124-3p synergistically damage the intestinal barrier in the aging colon. J Crohns Colitis 2021:jjab179. [PMID: 34628497 DOI: 10.1093/ecco-jcc/jjab179] [Reference Citation Analysis]
7 Horan MP, Cooper DN. The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease. Hum Genet 2014;133:435-58. [DOI: 10.1007/s00439-013-1402-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
8 Corridoni D, Chapman T, Ambrose T, Simmons A. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. Front Med (Lausanne) 2018;5:32. [PMID: 29515999 DOI: 10.3389/fmed.2018.00032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
9 Ballard JWO, Towarnicki SG. Mitochondria, the gut microbiome and ROS. Cell Signal 2020;75:109737. [PMID: 32810578 DOI: 10.1016/j.cellsig.2020.109737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Cunningham KE, Vincent G, Sodhi CP, Novak EA, Ranganathan S, Egan CE, Stolz DB, Rogers MB, Firek B, Morowitz MJ, Gittes GK, Zuckerbraun BS, Hackam DJ, Mollen KP. Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis. J Biol Chem 2016;291:10184-200. [PMID: 26969166 DOI: 10.1074/jbc.M115.688812] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
11 Jiang Z, Mu W, Yang Y, Sun M, Liu Y, Gao Z, Li J, Gu P, Wang H, Lu Y, Ba Q, Wang H. Cadmium exacerbates dextran sulfate sodium-induced chronic colitis and impairs intestinal barrier. Science of The Total Environment 2020;744:140844. [DOI: 10.1016/j.scitotenv.2020.140844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pascual-Itoiz MA, Peña-Cearra A, Martín-Ruiz I, Lavín JL, Simó C, Rodríguez H, Atondo E, Flores JM, Carreras-González A, Tomás-Cortázar J, Barriales D, Palacios A, García-Cañas V, Pellón A, Fullaondo A, Aransay AM, Prados-Rosales R, Martín R, Anguita J, Abecia L. The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis. Sci Rep 2020;10:572. [PMID: 31953445 DOI: 10.1038/s41598-019-57348-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 La Rosa SL, Leth ML, Michalak L, Hansen ME, Pudlo NA, Glowacki R, Pereira G, Workman CT, Arntzen MØ, Pope PB, Martens EC, Hachem MA, Westereng B. The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans. Nat Commun 2019;10:905. [PMID: 30796211 DOI: 10.1038/s41467-019-08812-y] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 24.7] [Reference Citation Analysis]
14 Rosa A, Abrantes P, Sousa I, Francisco V, Santos P, Francisco D, Xavier JM, Oliveira SA. Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control. Inflamm Bowel Dis 2016;22:774-81. [PMID: 26926037 DOI: 10.1097/MIB.0000000000000694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Baki E, Zwickel P, Zawierucha A, Ehehalt R, Gotthardt D, Stremmel W, Gauss A. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis. World J Gastroenterol 2015; 21(11): 3282-3290 [PMID: 25805935 DOI: 10.3748/wjg.v21.i11.3282] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 Han J, Zhao Q, Basmadjian C, Désaubry L, Theiss AL. Flavaglines Ameliorate Experimental Colitis and Protect Against Intestinal Epithelial Cell Apoptosis and Mitochondrial Dysfunction. Inflamm Bowel Dis 2016;22:55-67. [PMID: 26398710 DOI: 10.1097/MIB.0000000000000592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
17 Ruiz E, Penrose HM, Heller S, Nakhoul H, Baddoo M, Flemington EF, Kandil E, Savkovic SD. Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease. Gut Microbes 2020;11:350-63. [PMID: 31063017 DOI: 10.1080/19490976.2019.1611152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Özsoy M, Stummer N, Zimmermann FA, Feichtinger RG, Sperl W, Weghuber D, Schneider AM. Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac024. [PMID: 35247048 DOI: 10.1093/ibd/izac024] [Reference Citation Analysis]
19 Han J, Theiss AL. Stat3: friend or foe in colitis and colitis-associated cancer? Inflamm Bowel Dis. 2014;20:2405-2411. [PMID: 25185686 DOI: 10.1097/mib.0000000000000180] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
20 Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62. [PMID: 26484345 DOI: 10.3389/fcell.2015.00062] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 14.0] [Reference Citation Analysis]
21 Chun C, Zheng L, Colgan SP. Tissue metabolism and host-microbial interactions in the intestinal mucosa. Free Radic Biol Med 2017;105:86-92. [PMID: 27687211 DOI: 10.1016/j.freeradbiomed.2016.09.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
22 Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM. Precancer Atlas to Drive Precision Prevention Trials. Cancer Res 2017;77:1510-41. [PMID: 28373404 DOI: 10.1158/0008-5472.CAN-16-2346] [Cited by in Crossref: 73] [Cited by in F6Publishing: 40] [Article Influence: 14.6] [Reference Citation Analysis]
23 Clark A, Mach N. The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front Physiol 2017;8:319. [PMID: 28579962 DOI: 10.3389/fphys.2017.00319] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 24.2] [Reference Citation Analysis]
24 Kovács D, Vántus VB, Vámos E, Kálmán N, Schicho R, Gallyas F, Radnai B. Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells. Oxid Med Cell Longev 2021;2021:7308897. [PMID: 34567413 DOI: 10.1155/2021/7308897] [Reference Citation Analysis]
25 Abuaita BH, Lawrence AE, Berger RP, Hill DR, Huang S, Yadagiri VK, Bons B, Fields C, Wobus CE, Spence JR, Young VB, O'Riordan MX. Comparative transcriptional profiling of the early host response to infection by typhoidal and non-typhoidal Salmonella serovars in human intestinal organoids. PLoS Pathog 2021;17:e1009987. [PMID: 34669717 DOI: 10.1371/journal.ppat.1009987] [Reference Citation Analysis]
26 Ng GZ, Ke B, Laskowski A, Thorburn DR, Sutton P. No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis. Helicobacter 2017;22:e12378. [DOI: 10.1111/hel.12378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Sünderhauf A, Pagel R, Künstner A, Wagner AE, Rupp J, Ibrahim SM, Derer S, Sina C. Saccharin Supplementation Inhibits Bacterial Growth and Reduces Experimental Colitis in Mice. Nutrients 2020;12:E1122. [PMID: 32316544 DOI: 10.3390/nu12041122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Ho GT, Aird RE, Liu B, Boyapati RK, Kennedy NA, Dorward DA, Noble CL, Shimizu T, Carter RN, Chew ETS, Morton NM, Rossi AG, Sartor RB, Iredale JP, Satsangi J. MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunol 2018;11:120-30. [PMID: 28401939 DOI: 10.1038/mi.2017.31] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
29 Al Ojaimi Y, Khachab M, Bazzi S, Bahr GM, Echtay KS. Mitochondrial bioenergetics, uncoupling protein-2 activity, and reactive oxygen species production in the small intestine of a TNBS-induced colitis rat model. Mol Cell Biochem 2020;470:87-98. [PMID: 32394310 DOI: 10.1007/s11010-020-03749-z] [Reference Citation Analysis]
30 Boone DL, Teitell MA. The other genome: mitochondrial DNA and protection from experimental colitis. Gastroenterology 2013;145:933-5. [PMID: 24063944 DOI: 10.1053/j.gastro.2013.09.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes 2020;11:285-304. [PMID: 30913966 DOI: 10.1080/19490976.2019.1592421] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
32 Weiss CR, Guan Q, Ma Y, Qing G, Bernstein CN, Warrington RJ, Peng Z. The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis. PLoS One 2015;10:e0119004. [PMID: 25756273 DOI: 10.1371/journal.pone.0119004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
33 Jiang XG, Sun K, Liu YY, Yan L, Wang MX, Fan JY, Mu HN, Li C, Chen YY, Wang CS, Han JY. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism. Sci Rep 2017;7:41832. [PMID: 28150820 DOI: 10.1038/srep41832] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
34 Lyons J, Brubaker DK, Ghazi PC, Baldwin KR, Edwards A, Boukhali M, Strasser SD, Suarez-Lopez L, Lin YJ, Yajnik V, Kissil JL, Haas W, Lauffenburger DA, Haigis KM. Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis. Sci Signal 2018;11:eaan3580. [PMID: 29487189 DOI: 10.1126/scisignal.aan3580] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
35 Cunningham KE, Novak EA, Vincent G, Siow VS, Griffith BD, Ranganathan S, Rosengart MR, Piganelli JD, Mollen KP. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation. FASEB J 2019;33:1330-46. [PMID: 30113881 DOI: 10.1096/fj.201800535R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Schröder T, Kucharczyk D, Bär F, Pagel R, Derer S, Jendrek ST, Sünderhauf A, Brethack AK, Hirose M, Möller S, Künstner A, Bischof J, Weyers I, Heeren J, Koczan D, Schmid SM, Divanovic S, Giles DA, Adamski J, Fellermann K, Lehnert H, Köhl J, Ibrahim S, Sina C. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Mol Metab 2016;5:283-95. [PMID: 27069868 DOI: 10.1016/j.molmet.2016.01.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
37 Mottawea W, Chiang CK, Mühlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, Hajibabaei M, Singleton R, Benchimol EI, Jobin C, Mack DR, Figeys D, Stintzi A. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun 2016;7:13419. [PMID: 27876802 DOI: 10.1038/ncomms13419] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 27.5] [Reference Citation Analysis]
38 Sünderhauf A, Hicken M, Schlichting H, Skibbe K, Ragab M, Raschdorf A, Hirose M, Schäffler H, Bokemeyer A, Bettenworth D, Savitt AG, Perner S, Ibrahim S, Peerschke EI, Ghebrehiwet B, Derer S, Sina C. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis. Cell Mol Gastroenterol Hepatol 2021;12:229-50. [PMID: 33515804 DOI: 10.1016/j.jcmgh.2021.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
40 Colgan SP, Campbell EL, Kominsky DJ. Hypoxia and Mucosal Inflammation. Annu Rev Pathol 2016;11:77-100. [PMID: 27193451 DOI: 10.1146/annurev-pathol-012615-044231] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
41 Tourmente M, Hirose M, Ibrahim S, Dowling DK, Tompkins DM, Roldan ERS, Gemmell NJ. mtDNA polymorphism and metabolic inhibition affect sperm performance in conplastic mice. Reproduction 2017;154:341-54. [PMID: 28676531 DOI: 10.1530/REP-17-0206] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
42 Rath E, Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. [DOI: 10.1038/s41385-022-00514-x] [Reference Citation Analysis]
43 Han J, Yu C, Souza RF, Theiss AL. Prohibitin 1 modulates mitochondrial function of Stat3. Cell Signal. 2014;26:2086-2095. [PMID: 24975845 DOI: 10.1016/j.cellsig.2014.06.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
44 Chandraiah SB, Ghosh S, Saha I, More SS, Annappa GS, Maiti AK. Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis. 3 Biotech 2021;11:199. [PMID: 33927989 DOI: 10.1007/s13205-021-02755-2] [Reference Citation Analysis]
45 Dankowski T, Schröder T, Möller S, Yu X, Ellinghaus D, Bär F, Fellermann K, Lehnert H, Schreiber S, Franke A, Sina C, Ibrahim SM, König IR. Male-specific association between MT-ND4 11719 A/G polymorphism and ulcerative colitis: a mitochondria-wide genetic association study. BMC Gastroenterol 2016;16:118. [PMID: 27716073 DOI: 10.1186/s12876-016-0509-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 2020;54:1-7. [PMID: 32574708 DOI: 10.1016/j.mito.2020.06.008] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 32.5] [Reference Citation Analysis]
47 Han J, Li W, Shi G, Huang Y, Sun X, Sun N, Jiang D, Guan Q. Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/9129984] [Reference Citation Analysis]
48 Heller S, Penrose HM, Cable C, Biswas D, Nakhoul H, Baddoo M, Flemington E, Crawford SE, Savkovic SD. Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation. FASEB J 2017;31:2013-25. [PMID: 28183804 DOI: 10.1096/fj.201600976R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Jiang XG, Jiang MX, Wang F. Abnormal epithelial cell energy metabolism influences pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(27): 4393-4398 [DOI: 10.11569/wcjd.v23.i27.4393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]